GM1 ganglioside as a potential treatment in tardive dyskinesia

Psychopharmacology Bulletin

Volumn 25, Issue 2, 1989, Pages 277-280

  Peselow, E D ^a   Irons, S ^a   Rotrosen, J ^a   Alonso, M T ^a   Dorsey, F ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; GANGLIOSIDE GM1; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE;

CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; RATING SCALE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ADULT; AGED; DYSKINESIA, DRUG-INDUCED; G(M3) GANGLIOSIDE; GANGLIOSIDES; HUMAN; MIDDLE AGE;

EID: 0024468937     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)